Related Experiment Video
Updated: Jun 15, 2026

Real-Time Quantification of Reactive Oxygen Species in Neutrophils Infected with Meningitic Escherichia Coli
Published on: April 20, 2021
Association between the neutrophil myeloperoxidase index and subsets of bacterial infections
K Yonezawa1, O Horie, A Yoshioka
1Laboratory of Hematology, Division of Medical Biophysics, Kobe University Graduate School of Health Sciences, Suma-ku, Kobe, Japan.
Abstract:
The mean myeloperoxidase index (MPXI) is calculated during the routine complete blood count performed using the autoanalyzer ADVIA120/2120. The pattern of changes in the neutrophil myeloperoxidase levels in patients with specific infectious diseases was analyzed by assessing the MPXI levels. In patients with bacterial sepsis, identified by positive blood-culture tests, with (n = 29) and without (n = 51) systemic inflammatory response syndrome, the mean MPXI significantly reduced to -3.18 and -2.06, respectively. In contrast, among patients with nontuberculous nonseptic bacterial infections (n = 40), the mean MPXI significantly elevated to 5.51, while tuberculosis patients (n = 37) and patients with viral infection (n = 60) showed an unchanged MPXI (mean values, -0.46 and -1.06, respectively). Among the parameters of inflammation, only the C-reactive protein values showed a weak correlation with the MPXI levels. [Conclusion] These results indicate that MPXI is correlated with some specific infectious states, i.e. MPXI is low in bacterial sepsis and high in nontuberculous nonseptic bacterial infections. MPXI appears to be an independent and useful biomarker for the diagnosis and follow-up of infectious diseases, especially when the MPXI values are obtained at regular intervals during the disease courses of the patients.
Insights
The mean myeloperoxidase index (MPXI) is a useful biomarker for diagnosing infections. MPXI levels are low in bacterial sepsis and high in other bacterial infections, aiding in disease identification and monitoring.
Area of Science:
- Hematology
- Clinical Pathology
- Infectious Diseases
Background:
- Myeloperoxidase index (MPXI) is derived from complete blood counts.
- Neutrophil myeloperoxidase levels change in various infectious conditions.
Purpose of the Study:
- To analyze MPXI changes in patients with specific infectious diseases.
- To evaluate MPXI as a biomarker for diagnosing and monitoring infections.
Main Methods:
- MPXI was calculated using the ADVIA120/2120 autoanalyzer.
- MPXI levels were assessed in patients with bacterial sepsis, nontuberculous nonseptic bacterial infections, tuberculosis, and viral infections.
Main Results:
- Bacterial sepsis showed significantly reduced MPXI (-3.18 and -2.06).
- Nontuberculous nonseptic bacterial infections showed significantly elevated MPXI (5.51).
- Tuberculosis and viral infections showed unchanged MPXI (-0.46 and -1.06, respectively).
Conclusions:
- MPXI is a potential biomarker, low in sepsis and high in other bacterial infections.
- MPXI aids in diagnosing and monitoring infectious diseases, especially with regular measurements.

